FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

34555211000001103: Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104550701000001114 Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104550801000001117 Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has VMP Naltrexone 8mg / Bupropion 90mg modified-release tablets true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has specific active ingredient Naltrexone hydrochloride true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has specific active ingredient Bupropion hydrochloride true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Has basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Is a True Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start